Intra-Cellular Therapies
+$0.23 (+0.54%) As of 4:54 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.
About ITCI
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.
CEO
Sharon Mates
Employees
383
Headquarters
New York, New York
Founded
2013
ITCI Key Statistics
Market Cap
3.51B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
354.19K
High Today
$43.61
Low Today
$41.78
Open Price
$43.11
Volume
247.61K
52 Week High
$44.80
52 Week Low
$22.92
Analyst Ratings
100%
of 9 ratings
Buy
100%
Hold
0%
Sell
0%
ITCI Earnings
-$1.00
-$0.67
-$0.33
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market